FR1580899A - - Google Patents

Info

Publication number
FR1580899A
FR1580899A FR1580899DA FR1580899A FR 1580899 A FR1580899 A FR 1580899A FR 1580899D A FR1580899D A FR 1580899DA FR 1580899 A FR1580899 A FR 1580899A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1580899A publication Critical patent/FR1580899A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR1580899D 1968-03-29 1968-03-29 Expired FR1580899A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR146304 1968-03-29

Publications (1)

Publication Number Publication Date
FR1580899A true FR1580899A (en:Method) 1969-09-12

Family

ID=8648323

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1580899D Expired FR1580899A (en:Method) 1968-03-29 1968-03-29

Country Status (1)

Country Link
FR (1) FR1580899A (en:Method)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4854083A (en:Method) * 1971-11-17 1973-07-30
US4370332A (en) 1973-07-30 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
EP0780386A1 (en) * 1995-12-20 1997-06-25 F. Hoffmann-La Roche Ag Matrix metalloprotease inhibitors

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4854083A (en:Method) * 1971-11-17 1973-07-30
US4370332A (en) 1973-07-30 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
EP0780386A1 (en) * 1995-12-20 1997-06-25 F. Hoffmann-La Roche Ag Matrix metalloprotease inhibitors
US5932595A (en) * 1995-12-20 1999-08-03 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors

Similar Documents

Publication Publication Date Title
AU1946070A (en:Method)
AU428130B2 (en:Method)
AU5184069A (en:Method)
AU6168869A (en:Method)
AU6171569A (en:Method)
AU429879B2 (en:Method)
AU2581067A (en:Method)
AU4811568A (en:Method)
AU421558B1 (en:Method)
AR203075Q (en:Method)
AU3224368A (en:Method)
AU2580267A (en:Method)
AU4744468A (en:Method)
BE727867A (en:Method)
AU3083868A (en:Method)
AU4464266A (en:Method)
BE709435A (en:Method)
AU2496167A (en:Method)
BE727359A (en:Method)
BE709095A (en:Method)
AU4503667A (en:Method)
BE709446A (en:Method)
BE727204A (en:Method)
BE726689A (en:Method)
BE708888A (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse